Zachary Welch, Parker Bioscience, highlights single-use bioprocessing solutions presented at INTERPHEX 2022. Watch this video for insight regarding:
Parker
Advertisement
Articles by Parker
Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.
Advertisement
Latest Updated Articles
Mitigate Risk, Increase Speed & Reduce Complexity with Customized Single-Use SystemsPublished: February 22nd 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
4
Streamlining Procurement and Inventory Management Leads to Increased Productivity
5
